DAMORA THERAPEUTICS, INC. Money Market Funds, at Carrying Value
DAMORA THERAPEUTICS, INC. (DMRA) had Money Market Funds, at Carrying Value of $200.60 million as of 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Notes
us-gaap:MoneyMarketFundsAtCarryingValue · last filed 2026-03-19
- 2025-12-31: Money Market Funds, at Carrying Value $200.60M.
- 2024-12-31: Money Market Funds, at Carrying Value $5.90M.
- 2023-12-31: Money Market Funds, at Carrying Value $13.60M.
- 2022-12-31: Money Market Funds, at Carrying Value $16.40M.
| Period end | Money Market Funds, at Carrying Value |
|---|---|
| 2025-12-31 | $200.60M 10-K · filed 2026-03-19 |
| 2024-12-31 | $5.90M 10-K · filed 2026-03-19 |
| 2023-12-31 | $13.60M 10-K · filed 2025-03-19 |
| 2022-12-31 | $16.40M 10-K · filed 2024-03-08 |
| 2021-12-31 | $49.60M 10-K · filed 2023-03-09 |
| 2020-12-31 | $142.90M 10-K · filed 2022-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |